🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2026-526237-26-00
Completed Phase I

A Trial to Evaluate the Safety and Drug Levels of Single and Multiple Oral Doses of AT-587 in Healthy Adults

2026-526237-26-00 · tracked via the Priya Life Science EU tracker
Sponsor
Atea Pharmaceuticals Inc.
Sponsor type
Pharmaceutical company
Therapeutic area
Virus Diseases
Decision date
07/07/2026
Enrollment target
62
Sites
Belgium

Condition studied

Chronic hepatitis E virus (HEV) infection

Eligibility

Age group
18-64 years, 65+ years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2026-526237-26-00 on CTIS ↗ ← All trials in the EU